TY - JOUR
T1 - A novel liposome radiolabeling method using 99mTc-" SNS/S" complexes
T2 - In vitro and in vivo evaluation
AU - Bao, Ande
AU - Goins, Beth
AU - Klipper, Robert
AU - Negrete, George
AU - Mahindaratne, Mathew
AU - Phillips, William T.
N1 - Funding Information:
Authors thank San Antonio Area Foundation for financial support.
PY - 2003/9/1
Y1 - 2003/9/1
N2 - Liposomes are important carriers for controlled drug release, for gene or antisense therapy, and for immunization. Radiolabeled liposomes can be used to evaluate the in vivo behavior of different liposome formulations, as well as for diagnostic imaging and radionuclide therapy. A novel method for radiolabeling liposomes with 99mTc-"SNS/S" complexes is introduced. This labeling method can be applied to liposome radiolabeling with not only 99mTc but also two therapeutic radionuclides, 186Re and 188Re. Liposomes encapsulating glutathione (GSH) were studied for 99mTc labeling. N,N-bis(2-mercaptoethyl)-N′ ,N′-diethyl-ethylenediamine (BMEDA), N,N-bis(2-mercaptoethyl) -1-butylamine (BMBuA), and benzene thiol (BT) were investigated to make 99mTc-"BMEDA", 99mTc-"BMEDA + BT", 99mTc-"BMBuA", and 99mTc-"BMBuA + BT", for liposome labeling. The labeling efficiencies of 99mTc-GSH liposomes were from 36.9 to 69.2%. After incubation in serum, 99mTc-GSH liposomes labeled with 99mTc-"BMEDA" or 99mTc-"BMEDA + BT" had the best labeling stability of the formulations tested. Distribution studies after intravenous injection of 99mTc-liposomes composed of distearoyl phosphatidylcholine (DSPC) and cholesterol had a slow blood clearance and a high spleen accumulation demonstrating the in vivo labeling stability of the radiolabeled liposomes. The 99mTc-liposomes have great potential as a radiopharmaceutical system for evaluating various kinds of liposomes with different lipid composition, for evaluating in advance a subsequent radionuclide therapy using 186Re or 188Re labeled liposomes and for diagnostic imaging.
AB - Liposomes are important carriers for controlled drug release, for gene or antisense therapy, and for immunization. Radiolabeled liposomes can be used to evaluate the in vivo behavior of different liposome formulations, as well as for diagnostic imaging and radionuclide therapy. A novel method for radiolabeling liposomes with 99mTc-"SNS/S" complexes is introduced. This labeling method can be applied to liposome radiolabeling with not only 99mTc but also two therapeutic radionuclides, 186Re and 188Re. Liposomes encapsulating glutathione (GSH) were studied for 99mTc labeling. N,N-bis(2-mercaptoethyl)-N′ ,N′-diethyl-ethylenediamine (BMEDA), N,N-bis(2-mercaptoethyl) -1-butylamine (BMBuA), and benzene thiol (BT) were investigated to make 99mTc-"BMEDA", 99mTc-"BMEDA + BT", 99mTc-"BMBuA", and 99mTc-"BMBuA + BT", for liposome labeling. The labeling efficiencies of 99mTc-GSH liposomes were from 36.9 to 69.2%. After incubation in serum, 99mTc-GSH liposomes labeled with 99mTc-"BMEDA" or 99mTc-"BMEDA + BT" had the best labeling stability of the formulations tested. Distribution studies after intravenous injection of 99mTc-liposomes composed of distearoyl phosphatidylcholine (DSPC) and cholesterol had a slow blood clearance and a high spleen accumulation demonstrating the in vivo labeling stability of the radiolabeled liposomes. The 99mTc-liposomes have great potential as a radiopharmaceutical system for evaluating various kinds of liposomes with different lipid composition, for evaluating in advance a subsequent radionuclide therapy using 186Re or 188Re labeled liposomes and for diagnostic imaging.
KW - "SNS/S" complexes
KW - Liposomes
KW - Radiolabeling
KW - Stability
KW - Technetium-99m
UR - http://www.scopus.com/inward/record.url?scp=0041336621&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0041336621&partnerID=8YFLogxK
U2 - 10.1002/jps.10441
DO - 10.1002/jps.10441
M3 - Article
C2 - 12950007
AN - SCOPUS:0041336621
VL - 92
SP - 1893
EP - 1904
JO - Journal of Pharmaceutical Sciences
JF - Journal of Pharmaceutical Sciences
SN - 0022-3549
IS - 9
ER -